Emergence Of Robot-Assisted Eye Surgery


Posted November 12, 2018 by srikanthgtbrc

Asia Pacific was the largest region in the ophthalmic device market in 2017, accounting for around 33% of the total market. USA was the largest market accounting for around 22% of the total market

 
The use of robotic systems in the field of ophthalmology is increasing. Conventional ophthalmic surgeries are generally performed with a high magnification with a three-dimensional view through a surgical microscope and precise manipulations are made using delicate handheld instruments to minimize collateral damages. Robot-assisted surgeries are attractive in these cases and allow surgeons to perform complex eye operations with improved precision, amplified scale of motion, reduced tremor, task automation and flexibility. For instance, mechatronics and control laboratory and the Jules stein eye institute collaboratively developed intraocular robotic interventional and surgical system (IRISS) which is capable of performing both anterior and posterior segment intraocular surgery. This system consists of master surgical manipulators to manipulate two surgical instruments simultaneously through tiny ocular incisions and microscope mounted cameras for 3-D teleoperated surgical visualization. Preceyes BV also developed PRECEYES Surgical System to perform robot-assisted operation inside the eye.
THE BUSINESS RESEARCH COMPANY EXPECTS THE OPHTHALMIC DEVICES MARKET TO GROW TO $38 BILLION IN 2021
Asia Pacific was the largest region in the ophthalmic devices market in 2017, accounting for one-third of the market share.
Order the report at: https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report-2018
The chart below gives the forecast year-on-year growth of the global ophthalmic devices market during 2017 – 2021


According to The Business Research Company’s Consultant, Nitin Gianchandani, drug secreting contact lens are being developing to provide more effective treatment for patients struggling with difficult to self-administer and imprecise eye drops. Many eye conditions are treated with eye drops. But they do not work very well for more severe eye diseases such as corneal ulcers, glaucoma and chronic dry-eye, one of the many challenges of eye drops include very little amount of drug may actually pass through the cornea to reach eye and they will eventually enter into the blood stream. Drug-dispensing contacts overcome these problems and deliver the drug gradually into the eye which could improve treatment outcomes. For instance, Massachusetts Eye and Ear Infirmary, Massachusetts Institute of Technology, Harvard Medical School and Boston Children’s Hospital collaboratively developed a new drug-dispensing contact lens that can deliver glaucoma medication. Drug-eluting contact lenses are under investigation and so far, been tested only on an animal model.

Download a sample of the report at: https://www.thebusinessresearchcompany.com/sample.aspx?id=257&type=smp
Essilor International was the largest company in the ophthalmic devices market in 2017, with revenues of $7.9 billion in 2016. Essilor’s growth strategy aims to strengthen its presence in fast-growing countries, particularly through targeted acquisitions as well as developing new business models to make visual health accessible to a large proportion of population. In 2015, the company was involved in 19 new acquisitions and partnerships mainly in corrective lenses, sun wear and online.
Ophthalmic devices are an aid in the diagnosis, monitoring, surgery and treatment of various eye related diseases such as cataract, age-related macular degeneration, glaucoma, diabetic retinopathy, retinal detachment or tear, eye infections, dry eye syndrome and others. Companies in this ophthalmic device market engage in the manufacturing of a wide range of products such as contact lenses, glasses, intraocular lenses, diagnostics, retinal implants, stents, oculoplastics, lasers, surgical instruments and solutions.
Ophthalmic Devices Global Market Report 2018 is a detailed report giving a unique insight into this market. The report is priced at $4000 for an individual user. To use across your office, the price is $6000 and $8000 if you wish to use across a multinational company.

About The Business Research Company
Visit TheBusinessResearchCompany.com, mail [email protected] or call +447443439350 or +918897263534 or +919160996838 for more information on this and many other titles.
The Business Research Company is a market research and intelligence company, which excels in company, market and consumer research.
It has research professionals at its offices in the UK, India and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, chemicals and technology.
The Business Research Company's management has more than 20 years of varied business research experience. They have delivered hundreds of research projects to the senior management of some of the world's largest organizations.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Srikanth
Phone +442071930708
Business Address 47 Anchorage Point,
42 Cuba Street, Canary Wharf,
Country United Kingdom
Categories Business , Manufacturing , Marketing
Tags cataract surgery device market report , ophthalmic devices market report , ophthalmic diagnostic device market report , spectacles market report
Last Updated November 12, 2018